Gene therapy
Pro Research Analysisby 
Searched over 200M research papers for "gene therapy"
Gene Therapy Mechanisms and Delivery Systems
Gene therapy aims to treat or prevent diseases by introducing, removing, or altering genetic material within a patient’s cells. There are three main approaches: gene silencing (using siRNA, shRNA, or miRNA), gene replacement (delivering functional genes via plasmids or viral vectors), and gene editing (modifying mutations with tools like CRISPR/Cas, TALENs, or ZFNs) Sayed2022Dunbar2018. Delivery methods include viral vectors—such as adeno-associated virus (AAV), lentivirus, and retrovirus—and non-viral methods, which use physical (e.g., electroporation, microinjection), chemical (e.g., liposomes, nanoparticles), or biological techniques Sayed2022Saadi2021. Viral vectors are generally more efficient, but non-viral vectors offer advantages like lower immune responses .
Clinical Applications and Approved Therapies
Gene therapy has shown success in treating a range of diseases, including inherited immune disorders, hemophilia, congenital blindness, neuromuscular diseases, and certain cancers Keeler2017Dunbar2018Papanikolaou2021+3 MORE. Notable approved therapies include Glybera for lipoprotein lipase deficiency, Strimvelis for severe combined immune deficiency, and CAR-T cell therapies for B cell malignancies Keeler2017Dunbar2018Papanikolaou2021. In vivo delivery of AAV vectors has led to clinical improvements in conditions like congenital blindness and spinal muscular atrophy Dunbar2018Kohn2023. Ex vivo modification of hematopoietic stem cells and immune cells has enabled durable treatments for blood disorders and cancers Dunbar2018Papanikolaou2021Kohn2023.
Advances in Gene Editing Technologies
Recent years have seen the emergence of precise gene editing tools, such as CRISPR/Cas, which allow for targeted gene addition, correction, or ablation Sayed2022Dunbar2018Papanikolaou2021+1 MORE. These technologies can be applied ex vivo or delivered directly in vivo, expanding the potential for treating both monogenic and complex diseases Dunbar2018Papanikolaou2021Kaufmann2013. While gene addition therapies are already in clinical use, genome editing is still in early clinical stages but is expected to play a major role in the future Dunbar2018Papanikolaou2021.
Safety, Challenges, and Future Directions
Early gene therapy trials faced significant setbacks, including immune reactions and insertional mutagenesis, but advances in vector design and a better understanding of molecular mechanisms have improved safety and efficacy Dunbar2018Naldini2015Kaufmann2013. Current challenges include optimizing delivery efficiency, minimizing off-target effects, managing immune responses, and addressing the high costs and manufacturing complexities of these therapies Dunbar2018Naldini2015Anguela2019+1 MORE. Ethical considerations, especially regarding germline editing, and the need for new reimbursement models are also important issues as gene therapy becomes more widely adopted Dunbar2018Kohn2023.
Conclusion
Gene therapy has evolved from a theoretical concept to a clinical reality, offering hope for durable and potentially curative treatments for a variety of inherited and acquired diseases. Continued progress in delivery methods, gene editing technologies, and clinical applications is expected to further expand its impact, despite ongoing challenges related to safety, cost, and accessibility Sayed2022Dunbar2018Papanikolaou2021+3 MORE.
Sources and full results
Most relevant research papers on this topic